312 related articles for article (PubMed ID: 31132415)
21. Can Continuous Manufacturing of Topical Semisolids by Hot Melt Extrusion Soon Be a Reality?
Matadh AV; Echanur A; Suresh S; Chede L; Maibach H; Kulkarni V; Murthy SN; H N S
Mol Pharm; 2023 Aug; 20(8):3779-3790. PubMed ID: 37421361
[TBL] [Abstract][Full Text] [Related]
22. Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents.
Major I; McConville C
Recent Pat Drug Deliv Formul; 2015; 9(3):194-200. PubMed ID: 27165308
[TBL] [Abstract][Full Text] [Related]
23. Process analytical techniques for hot-melt extrusion and their application to amorphous solid dispersions.
Hitzer P; Bäuerle T; Drieschner T; Ostertag E; Paulsen K; van Lishaut H; Lorenz G; Rebner K
Anal Bioanal Chem; 2017 Jul; 409(18):4321-4333. PubMed ID: 28343348
[TBL] [Abstract][Full Text] [Related]
24. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation-Where Are We Now?
Patil H; Vemula SK; Narala S; Lakkala P; Munnangi SR; Narala N; Jara MO; Williams RO; Terefe H; Repka MA
AAPS PharmSciTech; 2024 Feb; 25(2):37. PubMed ID: 38355916
[TBL] [Abstract][Full Text] [Related]
25. Melt extrusion with poorly soluble drugs - An integrated review.
Repka MA; Bandari S; Kallakunta VR; Vo AQ; McFall H; Pimparade MB; Bhagurkar AM
Int J Pharm; 2018 Jan; 535(1-2):68-85. PubMed ID: 29102700
[TBL] [Abstract][Full Text] [Related]
26. Application of hot melt extrusion for poorly water-soluble drugs: limitations, advances and future prospects.
Lu M; Guo Z; Li Y; Pang H; Lin L; Liu X; Pan X; Wu C
Curr Pharm Des; 2014; 20(3):369-87. PubMed ID: 23651401
[TBL] [Abstract][Full Text] [Related]
27. Recent Progress in Hot Melt Extrusion Technology in Pharmaceutical Dosage Form Design.
Salave S; Prayag K; Rana D; Amate P; Pardhe R; Jadhav A; Jindal AB; Benival D
Recent Adv Drug Deliv Formul; 2022; 16(3):170-191. PubMed ID: 35986528
[TBL] [Abstract][Full Text] [Related]
28. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.
Bandari S; Nyavanandi D; Dumpa N; Repka MA
Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550
[TBL] [Abstract][Full Text] [Related]
29. Process monitoring and visualization solutions for hot-melt extrusion: a review.
Saerens L; Vervaet C; Remon JP; De Beer T
J Pharm Pharmacol; 2014 Feb; 66(2):180-203. PubMed ID: 24433422
[TBL] [Abstract][Full Text] [Related]
30. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
31. Amorphous solid dispersions of cyclosporine A with improved bioavailability prepared via hot melt extrusion: Formulation, physicochemical characterization, and in vivo evaluation.
Jiang X; Zhao Y; Guan Q; Xiao S; Dong W; Lian S; Zhang H; Liu M; Wang Z; Han J
Eur J Pharm Sci; 2022 Jan; 168():106036. PubMed ID: 34637896
[TBL] [Abstract][Full Text] [Related]
32. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
[TBL] [Abstract][Full Text] [Related]
33. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.
Lacerda SP; Del Confetto S; Haurie L; Bernard M; Faget S; Ré MI
Pharm Dev Technol; 2024 Feb; 29(2):131-142. PubMed ID: 38235570
[TBL] [Abstract][Full Text] [Related]
34. Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions.
Palekar S; Mamidi HK; Guo Y; Vartak R; Patel K
Int J Pharm; 2023 Jun; 640():122989. PubMed ID: 37120123
[TBL] [Abstract][Full Text] [Related]
35. A quality by design approach to develop topical creams via hot-melt extrusion technology.
Mendonsa NS; Pradhan A; Sharma P; Prado RMB; Murthy SN; Kundu S; Repka MA
Eur J Pharm Sci; 2019 Aug; 136():104948. PubMed ID: 31173868
[TBL] [Abstract][Full Text] [Related]
36. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.
LaFountaine JS; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):43-55. PubMed ID: 26307759
[TBL] [Abstract][Full Text] [Related]
37. Hot melt extrusion of ion-exchange resin for taste masking.
Tan DCT; Ong JJ; Gokhale R; Heng PWS
Int J Pharm; 2018 Aug; 547(1-2):385-394. PubMed ID: 29859323
[TBL] [Abstract][Full Text] [Related]
38. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century.
Tiwari RV; Patil H; Repka MA
Expert Opin Drug Deliv; 2016; 13(3):451-64. PubMed ID: 26886062
[TBL] [Abstract][Full Text] [Related]
39. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
Tran PHL; Lee BJ; Tran TTD
Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
[TBL] [Abstract][Full Text] [Related]
40. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
Patil H; Feng X; Ye X; Majumdar S; Repka MA
AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
